Analysed SILEXION THERAPEUTICS CORP (SLXN:NASDAQ) News Sources
Silexion Therapeutics Urges Shareholders to Vote Ahead of March 16 Extraordinary General Meeting
05-03-2026
yahoo.com
Silexion Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
17-03-2026
yahoo.com
Silexion Therapeutics Receives Approval from Israeli Ministry of Health to Initiate Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer
24-03-2026
yahoo.com
Silexion Therapeutics Announces Successful Submission of Phase 2/3 Clinical Trial Application to Germany’s BfArM for SIL204 in KRAS-Driven Locally Advanced Pancreatic Cancer
28-04-2026
yahoo.com
Silexion Therapeutics Announces Initiation of GMP Clinical Supply Manufacturing of SIL204 with Leading Global CDMO, and New Approval of Phase 2/3 Trial From Tel Aviv Sourasky Medical Center
13-05-2026
yahoo.com
Silexion Therapeutics Reports Positive Preliminary Immunotherapy Findings for SIL204 in KRAS-Driven Pancreatic Cancer
14-05-2026
yahoo.com
Silexion Therapeutics Announces Exercise of Warrants for $1 Million Gross Proceeds
15-05-2026
yahoo.com
Silexion Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
18-05-2026
yahoo.com
What is the current price of SILEXION THERAPEUTICS CORP (SLXN:NASDAQ)?
The current price of SILEXION THERAPEUTICS CORP (SLXN:NASDAQ) is $3.13.
SILEXION THERAPEUTICS CORP (SLXN:NASDAQ) absolute price change since previous trading day?
The absolute price change of SILEXION THERAPEUTICS CORP (SLXN:NASDAQ) since the previous trading day is $0.04.
SILEXION THERAPEUTICS CORP (SLXN:NASDAQ) percentage price change since previous trading day?
The percentage price change of SILEXION THERAPEUTICS CORP (SLXN:NASDAQ) since the previous trading day is 1.2945%.
What is the most recent average sentiment score for SILEXION THERAPEUTICS CORP (SLXN:NASDAQ)?
The most recent average sentiment score for SILEXION THERAPEUTICS CORP (SLXN:NASDAQ) is 71 out of 100.
What is the most recent average sentiment for SILEXION THERAPEUTICS CORP (SLXN:NASDAQ)?
The most recent sentiment for SILEXION THERAPEUTICS CORP (SLXN:NASDAQ) is .
SEC-8K** Filing Available For SILEXION THERAPEUTICS CORP (SLXN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.